Towards Healthcare
Life Sciences IT Market to Reach USD 67.69 Billion by 2034

Life Sciences IT Market 2025 Overview Key Innovations from Roche, QIAGEN, Clario, and ACG Inspection

Projections indicate that, the global life sciences IT market will increase from USD 23.71 billion in 2024 to USD 67.69 billion by 2034, experiencing a CAGR of 11.06% over the next 10 years. The market is growing due to increasing digitalization in drug development, clinical trials, and healthcare data management. Rising demand for AI, cloud computing, and data analytics is further accelerating market expansion.

  • Insight Code: 5891
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The life sciences IT market is projected to reach USD 67.69 billion by 2034, growing at a CAGR of 11.06% from 2024 to 2034.

North America is currently leading the healthcare cybersecurity market due to its strong presence of leading pharmaceutical and biotech companies, advanced healthcare infrastructure, and high adoption of digital technologies.

The life sciences IT market includes 5 segments by component, by deployment mode, by application, by end user, by workflow, and by region.

Some key players include Oracle Life Sciences, Veeva Systems, IQVIA, Medidata, SAP SE

Key trends include the growth due to increasing digitalization in drug development, clinical trials, and healthcare data management.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.